Ready-to-use solution, developed in collaboration with GenScript, offers rapid and reliable quantification of His-tagged proteins Broadens Amperia’s applications across recombinant protein research, screening, and development Abselion to showcase kit alongside Amperia platform at PEGS Europe in Lisbon, Portugal from 11–13 November Cambridge, UK: Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, has […]
Redefining Scalability, Automation, and Clinical Yield in Genomic Interpretation BOZEMAN, Mont. — Golden Helix, Inc. announced the release of VarSeq 3 and VSWarehouse 3, the company’s next-generation platform for secondary and tertiary genomic analysis. Building on more than a decade of trusted innovation, the clinical utility of VarSeq 3 has been expanded through industry partnerships and customer collaborations. […]
Funding will accelerate commercialization of its breakthrough biomarker detection platform MUSE®. Oberkochen, Germany | ZEISS Group ZEISS Ventures participated in an oversubscribed financing round of CHF 6.3 million for arcoris bio, a Swiss start-up specializing in a platform technology aimed at enhancing biomolecule detection and imaging for spatial multiomics solutions. The funding round, co-led by […]
Integrates Alithea Genomics’ MERCURIUS FLASH-seq single-cell RNA-seq protocol with SPT Labtech’s firefly liquid handling platform Enables higher-throughput, cost efficient single-cell sequencing Cambridge, UK, and Lausanne, Switzerland — SPT Labtech, a global leader in the design and development of laboratory automation and liquid handling solutions, and Alithea Genomics, a pioneer in the field of large-scale RNA sequencing […]
NanoTemper Strengthens Biopharma Discovery Portfolio with Acquisition of Envue Technologies and Launch of Dianthus™ α NanoTemper’s two strategic milestones – NSM technology acquisition and the launch of Dianthus™ α application – expand its capabilities across the life sciences value chain and enhance support for the discovery of next-generation therapeutics. The Envue Technologies acquisition brings Nanofluidic Scattering […]
CAMBRIDGE, England — Novogene Europe is pleased to announce the launch of its new Whole Plasmid Sequencing service, powered by Oxford Nanopore Technologies (ONT). This service offering represents a major step forward in plasmid verification, providing researchers with a powerful and practical alternative to traditional Sanger sequencing. Unlike conventional approaches, whole plasmid sequencing delivers a […]
– TAPS+ enables simultaneous detection of methylation and genetic variants, unlocking new insights for precision oncology and translational research. – Preserves DNA integrity in challenging clinically relevant samples, including FFPE tissue and circulating tumor DNA (ctDNA). – Platform-agnostic chemistry enables seamless integration across sequencing systems. BOULDER, Colo. — Watchmaker Genomics today announced the launch of TAPS+, a next-generation technology […]
LONDON, UK — Touchlight, a leader in cell-free DNA technology, today announced the expansion of its groundbreaking mbDNA™ platform with the introduction of three new circular DNA architectures: sscDNA, hsscDNA, and dscDNA. These innovative constructs join mbDNA, which debuted earlier this year, to form a comprehensive portfolio designed to overcome the limitations of traditional gene editing tools. […]
SAN DIEGO — The Chinese Ministry of Commerce (MOFCOM) today announced it will lift the export ban on Illumina, Inc. (NASDAQ: ILMN), which had been in place since March 4, 2025. While the ban will be lifted on November 10, Illumina remains on the Unreliable Entities List (UEL), requiring government approval for instrument purchases. Illumina remains focused […]
Nightingale Health (Nasdaq Helsinki: HEALTH; OTCQX: NHLTY, NGHLF), a pioneer in disease risk detection and global leader in metabolomics, announces a strategic partnership with Alamar Biosciences to integrate cutting-edge brain health proteomics into its multiomics portfolio. This collaboration enables comprehensive multiomics analysis from a single blood sample – available only from Nightingale Health. Nightingale Health’s […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
